Dartmouth Health Continuing Education for Professionals Home, AXL: Advanced Opioid Use Disorder X-waiver Team Learning Collaborative: Co-occurring Mental Illness and Substance Use, 9/1/2021 8:00:00 AM - 9/1/2024 10:00:00 AM, This session reviews strategies for MAT team member collaboration on care management of a psychiatric condition commonly co-occurring with Opioid Use Disorder including Depressive Disorders, Anxiety Disorders, and Cluster B Personality Disorders.
Presentations will review strategies for team collaboration regarding:
• Jenny Beaudin currently serves as Clara Martin Center’s MAT Coordinator in Randolph, Vermont. Jenny began her professional career as a whale biologist working with the New England Aquarium in Boston. Later, she earned her Master’s degree at Vermont Law School. Over the next 15 years, Jenny worked to support victims/survivors of domestic and sexual violence. For nine of those years, she was a supervisor for the statewide Intensive Domestic Abuse Program (IDAP); a Department of Corrections based program for violent offenders with domestic violence related offenses. Her love of science, belief in people’s ability to change, and interest in working with criminal justice involved individuals lead Jenny to pursue a career in counseling. Jenny joined the Clara Martin Center in 2015 as the School Based Services Program Director while she earned her Master’s degree in Clinical Mental Health Counseling. She worked as a Criminal Justice and Substance Use clinician prior to transferring into her current MAT role.
• Christopher Chadwick is a Licensed Behavioral Therapist and an Accredited Forensic Specialist in Forensic Counseling. Christopher has over 20 years of experience in the social services field including complex multi-faceted therapy, law enforcement, Drug Courts and experience working within the prison system. He is a graduate of Norwich University with a Master’s Degree, Florida Southern College for his Undergraduate Degree. He currently serves as the Director of Behavioral Health & MAT Services for Community Health Centers of Rutland Region where he oversees all Behavioral Health and Medicated Assisted Treatment services. He is the Manager of the Impaired Driver Rehabilitation Program (IDRP) overseeing the White River Junction and Rutland programs through Rutland Mental Health Services. He is the owner / Director of Forensic Consultation & Counseling Service, LLC. He is an adjunct professor for Castleton University teaching in the Psychology / Social Work Department. He has served as a consultant for private businesses, government agencies for incorporating behavioral health and substance abuse policies.
• Laura M. Dewey is a MAT Clinician and Integrated Mental Health Counselor at Cold Hollow Family Practice. Laura began her work at a residential treatment program in Burlington Vermont providing treatment for parenting and/or pregnant women, as well as their families. Her work expanded as a Substance Use Counselor in a women’s correctional facility as well as a SBIRT Clinician in an Emergency Department. Laura has been trained in group and individual therapy and has specialized in providing treatment for those with substance use disorders, Mediation Assisted Treatment, and Co-Occurring Disorders.
Learning Outcome(s)
Participants will be able to identify at least three evidence-based strategies that are designed to enhance the clinical team-based care of patients with substance or opioid use disorders treatment.
Disclosure
The activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for this activity have reported NO financial relationship(s)* with ineligible companies**.
* A “financial relationship" includes employee, researcher (named as the PI), consultant, advisor, speaker, independent contractor (including contracted research), royalties or patent beneficiary, executive role, and/or an ownership interest (not including stocks owned in a managed portfolio).
** An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Bibliographic Resources
• Anxiety & Depression Association of America (2021, April 21). Facts & Statistics: Anxiety and Depression Association of America, ADAA. Facts & Statistics | Anxiety and Depression Association of America, ADAA. https://adaa.org/understanding-anxiety/facts-statistics
• SAMHSA.(n.d.). Understanding Anxiety Disorders Caregiver: Get the Facts. Understanding Anxiety Disorders Caregiver: Get the Facts | SAMHSA Publications and Digital Products. https://store.samhsa.gov/product/Understanding-Anxiety-Disorders-Caregiver-Get-the-Facts/SMA16-5009.
• Grant,BF, Stinson,FS, Dawson,DA, etal. Prevalence and co-occurrence of substance used isorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2004; 61:807.
• Edited by Editorial Staff Last Updated: February 3, 2020. (2020,February3). Treating Addiction with Anxiety Disorders. American Addiction Centers. https://americanaddictioncenters.org/anxiety-and-addiction.
• American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental disorders (5th ed., p. ). American Psychiatric Association.
• Breivik, R., Wilberg, T., Evensen, J., Røssberg, J. I., Dahl, H. S. J., & Pedersen, G. (2020). Countertransference feelings and personality disorders: a psychometric evaluation of a brief version of the Feeling Word Checklist (FWC-BV). BMC Psychiatry, 20(1). https://doi.org/10.1186/s12888-020- 02556-6
• Hancock, C. (2017). The Stigma Associated with Borderline Personality Disorder | NAMI: National Alliance on Mental Illness. Nami.org. https://www.nami.org/Blogs/NAMI-Blog/June-2017/The-Stigma- Associated-with-Borderline-Personality
• Implications for Treatment and Prognosis of Borderline and Substance Use Disorders. (n.d.). Psychiatric Times. Retrieved June 24, 2021, from https://www.psychiatrictimes.com/view/implications-treatment- and-prognosis-borderline-and-substance-use-disorders
• O’Sullivan, M.-K. (2020, August 27). Cluster B Personality Disorders: Antisocial, Borderline, Histrionic, and Narcissistic [Review of Cluster B Personality Disorders: Antisocial, Borderline, Histrionic, and Narcissistic].
Presentations will review strategies for team collaboration regarding:
- Mental health first aid
- Acute risk identification and mitigation
- Engagement in treatments for co-occurring conditions
- MAT engagement impacted by co-occurring condition
- Patient behaviors disruptive of clinic and/or other patient functioning
• Jenny Beaudin currently serves as Clara Martin Center’s MAT Coordinator in Randolph, Vermont. Jenny began her professional career as a whale biologist working with the New England Aquarium in Boston. Later, she earned her Master’s degree at Vermont Law School. Over the next 15 years, Jenny worked to support victims/survivors of domestic and sexual violence. For nine of those years, she was a supervisor for the statewide Intensive Domestic Abuse Program (IDAP); a Department of Corrections based program for violent offenders with domestic violence related offenses. Her love of science, belief in people’s ability to change, and interest in working with criminal justice involved individuals lead Jenny to pursue a career in counseling. Jenny joined the Clara Martin Center in 2015 as the School Based Services Program Director while she earned her Master’s degree in Clinical Mental Health Counseling. She worked as a Criminal Justice and Substance Use clinician prior to transferring into her current MAT role.
• Christopher Chadwick is a Licensed Behavioral Therapist and an Accredited Forensic Specialist in Forensic Counseling. Christopher has over 20 years of experience in the social services field including complex multi-faceted therapy, law enforcement, Drug Courts and experience working within the prison system. He is a graduate of Norwich University with a Master’s Degree, Florida Southern College for his Undergraduate Degree. He currently serves as the Director of Behavioral Health & MAT Services for Community Health Centers of Rutland Region where he oversees all Behavioral Health and Medicated Assisted Treatment services. He is the Manager of the Impaired Driver Rehabilitation Program (IDRP) overseeing the White River Junction and Rutland programs through Rutland Mental Health Services. He is the owner / Director of Forensic Consultation & Counseling Service, LLC. He is an adjunct professor for Castleton University teaching in the Psychology / Social Work Department. He has served as a consultant for private businesses, government agencies for incorporating behavioral health and substance abuse policies.
• Laura M. Dewey is a MAT Clinician and Integrated Mental Health Counselor at Cold Hollow Family Practice. Laura began her work at a residential treatment program in Burlington Vermont providing treatment for parenting and/or pregnant women, as well as their families. Her work expanded as a Substance Use Counselor in a women’s correctional facility as well as a SBIRT Clinician in an Emergency Department. Laura has been trained in group and individual therapy and has specialized in providing treatment for those with substance use disorders, Mediation Assisted Treatment, and Co-Occurring Disorders.
Learning Outcome(s)
Participants will be able to identify at least three evidence-based strategies that are designed to enhance the clinical team-based care of patients with substance or opioid use disorders treatment.
Disclosure
The activity director(s), planning committee member(s), speaker(s), author(s) or anyone in a position to control the content for this activity have reported NO financial relationship(s)* with ineligible companies**.
* A “financial relationship" includes employee, researcher (named as the PI), consultant, advisor, speaker, independent contractor (including contracted research), royalties or patent beneficiary, executive role, and/or an ownership interest (not including stocks owned in a managed portfolio).
** An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Bibliographic Resources
• Anxiety & Depression Association of America (2021, April 21). Facts & Statistics: Anxiety and Depression Association of America, ADAA. Facts & Statistics | Anxiety and Depression Association of America, ADAA. https://adaa.org/understanding-anxiety/facts-statistics
• SAMHSA.(n.d.). Understanding Anxiety Disorders Caregiver: Get the Facts. Understanding Anxiety Disorders Caregiver: Get the Facts | SAMHSA Publications and Digital Products. https://store.samhsa.gov/product/Understanding-Anxiety-Disorders-Caregiver-Get-the-Facts/SMA16-5009.
• Grant,BF, Stinson,FS, Dawson,DA, etal. Prevalence and co-occurrence of substance used isorders and independent mood and anxiety disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Arch Gen Psychiatry 2004; 61:807.
• Edited by Editorial Staff Last Updated: February 3, 2020. (2020,February3). Treating Addiction with Anxiety Disorders. American Addiction Centers. https://americanaddictioncenters.org/anxiety-and-addiction.
• American Psychiatric Association. (2013). Diagnostic and Statistical Manual of Mental disorders (5th ed., p. ). American Psychiatric Association.
• Breivik, R., Wilberg, T., Evensen, J., Røssberg, J. I., Dahl, H. S. J., & Pedersen, G. (2020). Countertransference feelings and personality disorders: a psychometric evaluation of a brief version of the Feeling Word Checklist (FWC-BV). BMC Psychiatry, 20(1). https://doi.org/10.1186/s12888-020- 02556-6
• Hancock, C. (2017). The Stigma Associated with Borderline Personality Disorder | NAMI: National Alliance on Mental Illness. Nami.org. https://www.nami.org/Blogs/NAMI-Blog/June-2017/The-Stigma- Associated-with-Borderline-Personality
• Implications for Treatment and Prognosis of Borderline and Substance Use Disorders. (n.d.). Psychiatric Times. Retrieved June 24, 2021, from https://www.psychiatrictimes.com/view/implications-treatment- and-prognosis-borderline-and-substance-use-disorders
• O’Sullivan, M.-K. (2020, August 27). Cluster B Personality Disorders: Antisocial, Borderline, Histrionic, and Narcissistic [Review of Cluster B Personality Disorders: Antisocial, Borderline, Histrionic, and Narcissistic].
